ArticleJournal of clinical hypertension (Greenwich, Conn.)2025
Association Between Cumulative Estimated Pulse Wave Velocity and the Risk of Major Adverse Cardiovascular Events in Adults over 45 Years of Age: A Longitudinal Study Based on the CHARLS and Kailuan Cohorts.
Article in Journal of clinical hypertension (Greenwich, Conn.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association between estimated pulse wave velocity and impaired fasting glucose: a multicenter retrospective cohort study in China.Frontiers in endocrinology · 2026Article
- Association Between Cumulative Estimated Pulse Wave Velocity and the Risk of Major Adverse Cardiovascular Events in Adults over 45 Years of Age: A Longitudinal Study Based on the CHARLS and Kailuan Cohorts.Journal of clinical hypertension (Greenwich, Conn.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Estimated pulse wave velocity (ePWV) is a widely used metric for assessing arterial stiffness, a key pathophysiological mechanism contributing to major adverse cardiovascular events (MACEs). While cross-sectional and short-term associations of ePWV with cardiovascular risk are recognized, the long-term impact of cumulative exposure to elevated ePWV levels on the risk of developing MACEs remains poorly understood, particularly in middle-aged and older adults. This longitudinal study analyzed data from two large prospective cohorts: the Kailuan Study (n = 3568; 65% male) and the China Health and Retirement Longitudinal Study (CHARLS) (n = 4831; 48% male). Individual ePWV was calculated based on age and mean arterial pressure. Cumulative ePWV exposure was quantified as the summed area under the curve between serial measurements. The primary outcome was the incidence of MACEs. Cox regression revealed significant positive associations between cumulative ePWV and MACEs risk, with the highest ePWV quartile showing substantially elevated risk compared to the lowest quartile in both the Kailuan (HR = 2.01; 95% CI: 1.34-3.01) and CHARLS cohorts (HR = 1.73; 95% CI: 1.03-2.91). Subgroup analyses demonstrated similar positive associations across key demographic and clinical strata. Long-term cumulative exposure to elevated ePWV independently predicts MACEs in adults aged ≥45 years. Critically, this association persists after rigorous adjustment for baseline ePWV and key confounders, highlighting the unique prognostic value of tracking arterial stiffness burden over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.